Records containing: Myelodysplastic/Myeloproliferative Diseases
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-05-10A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Unrelated Donors in Patients With Advanced Hematologic Malignancies and Hematological Disorders
-
CLINICAL_TRIALS study record update · 2021-08-13Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2020-07-27Pilot Study Of Multiple Umbilical Cord Blood Unit Transplantation Following Non-Myeloablative Conditioning In Patients With Hematologic Disorders Or Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2020-07-27Immunomodulation by Ultraviolet B-Irradiation (UVB) to Facilitate Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2020-07-27A Phase II Trial of Combination Therapy With Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients With Chronic Idiopathic Myelofibrosis or Overlap Myelodysplastic/Myeloproliferative Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-02-10Non-Myeloablative Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies and Disorders
-
CLINICAL_TRIALS study record update · 2019-12-17An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2019-11-19Phase II Study of Doxercalciferol for the Treatment of Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2019-09-17Low Dose Total-Body Irradiation And Fludarabine Followed By HLA Matched Allogeneic Stem Cell Transplantation For Hematologic Malgnancies - A Multi-Center Study
-
CLINICAL_TRIALS study record update · 2018-09-05A Phase II Study of Bexarotene + Sargromastastin as Agents of Differentiation in MDS and AML
-
CLINICAL_TRIALS study record update · 2018-04-03Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation With a Conditioning Regimen of Targeted Busulfan, Cyclophosphamide, and Thymoglobulin
-
CLINICAL_TRIALS study record update · 2018-01-26Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support
-
CLINICAL_TRIALS study record update · 2017-12-02Phase II Study of Intravenous Ganciclovir Followed by Oral Ganciclovir in the Treatment of Reactivation of CMV Following Bone Marrow Transplant
-
CLINICAL_TRIALS study record update · 2017-11-29Transplantation of Umbilical Cord Blood From Related and Unrelated Donors
-
CLINICAL_TRIALS study record update · 2017-09-29A Phase I, Dose-Finding Trial of Sodium Phenylbutrate (NSC 657802) in Combination With All Trans-retinoic Acid (ATRA, NSC 122758) in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2017-06-14Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
-
CLINICAL_TRIALS study record update · 2017-05-24A Prospective Trial to Evaluate the Role of In Vivo T Cell Depletion by Campath® (Alemtuzumab) in Reduction of Transplant Related Mortality in Transplantation From HLA-Class I or Class II Mismatched, Unrelated Donors
-
CLINICAL_TRIALS study record update · 2014-04-17Phase III Trial of T Lymphocyte Depletion by Elutriation and CD34 Add-Back for Allogeneic Bone Marrow Transplantation
-
CLINICAL_TRIALS study record update · 2014-04-17Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) After T-Lymphocyte Depleted Allogeneic BMT for Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2014-02-03The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia
-
CLINICAL_TRIALS study record update · 2013-12-18Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-24Hematopoietic Stem Cell Transplantation Using Bone Marrow Or Peripheral Blood Stem Cells From Matched, Unrelated, Volunteer Donors
-
CLINICAL_TRIALS study record update · 2013-05-01Pilot Study Of T-Cell-Depleted Peripheral Blood Stem Cell Transplantation From Partially Matched Related Donors For Patients With High-Risk Leukemia
-
CLINICAL_TRIALS study record update · 2012-10-02Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-10-01Pre-administration of Rabbit Antithymocyte Globulin to Optimize Donor T-Cell Engraftment Following Reduced Intensity Allogeneic Peripheral Blood Progenitor Cell Transplantation From Matched-Related Donors